PubMed

PPAR gamma variant influences angiographic outcome and 10-year cardiovascular risk in male symptomatic coronary artery disease patients.

Regieli JJ, Jukema JW, Doevendans PA, Zwinderman AH, van der Graaf Y, Kastelein JJ, Grobbee DE.

Diabetes Care. 2009 May;32(5):839-44. Epub 2009 Feb 19.PMID: 19228871 [PubMed - indexed for MEDLINE]Related articlesFree article

No association of Pro12Ala polymorphism of PPAR-gamma gene with coronary artery disease in Korean subjects.

Rhee EJ, Kwon CH, Lee WY, Kim SY, Jung CH, Kim BJ, Sung KC, Kim BS, Oh KW, Kang JH, Park SW, Kim SW, Lee MH, Park JR.

Circ J. 2007 Mar;71(3):338-42.PMID: 17322631 [PubMed - indexed for MEDLINE]Related articlesFree article

PPARgamma gene C161T substitution is associated with reduced risk of coronary artery disease and decreased proinflammatory cytokine expression.

Liu Y, Yuan Z, Liu Y, Zhang J, Yin P, Wang D, Wang Y, Kishimoto C, Ma A.

Am Heart J. 2007 Oct;154(4):718-24. Epub 2007 Aug 27.PMID: 17892998 [PubMed - indexed for MEDLINE]Related articles

Paraoxonase variants relate to 10-year risk in coronary artery disease: impact of a high-density lipoprotein-bound antioxidant in secondary prevention.

Regieli JJ, Jukema JW, Doevendans PA, Zwinderman AH, Kastelein JJ, Grobbee DE, van der Graaf Y.

J Am Coll Cardiol. 2009 Sep 29;54(14):1238-45.PMID: 19778663 [PubMed - indexed for MEDLINE]Related articles

Changes in insulin sensitivity in response to troglitazone do not differ between subjects with and without the common, functional Pro12Ala peroxisome proliferator-activated receptor-gamma2 gene variant: results from the Troglitazone in Prevention of Diabetes (TRIPOD) study.

Snitker S, Watanabe RM, Ani I, Xiang AH, Marroquin A, Ochoa C, Goico J, Shuldiner AR, Buchanan TA; Troglitazone in Prevention of Diabetes (TRIPOD) study.

Diabetes Care. 2004 Jun;27(6):1365-8.PMID: 15161789 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of two common polymorphisms of peroxisome proliferator-activated receptor-gamma gene on metabolic syndrome.

Rhee EJ, Oh KW, Lee WY, Kim SY, Oh ES, Baek KH, Kang MI, Kim SW.

Arch Med Res. 2006 Jan;37(1):86-94.PMID: 16314192 [PubMed - indexed for MEDLINE]Related articles

Role of genetic polymorphism peroxisome proliferator-activated receptor-gamma2 Pro12Ala on ethnic susceptibility to diabetes in South-Asian and Caucasian subjects: Evidence for heterogeneity.

Radha V, Vimaleswaran KS, Babu HN, Abate N, Chandalia M, Satija P, Grundy SM, Ghosh S, Majumder PP, Deepa R, Rao SM, Mohan V.

Diabetes Care. 2006 May;29(5):1046-51.PMID: 16644635 [PubMed - indexed for MEDLINE]Related articlesFree article

A Pro12Ala polymorphism in the human peroxisome proliferator-activated receptor-gamma 2 is associated with combined hyperlipidaemia in obesity.

Swarbrick MM, Chapman CM, McQuillan BM, Hung J, Thompson PL, Beilby JP.

Eur J Endocrinol. 2001 Mar;144(3):277-82.PMID: 11248748 [PubMed - indexed for MEDLINE]Related articlesFree article

PPARgamma Pro12Ala polymorphism and risk of acute coronary syndrome in a prospective study of Danes.

Vogel U, Segel S, Dethlefsen C, Tjønneland A, Saber AT, Wallin H, Jensen MK, Schmidt EB, Andersen PS, Overvad K.

BMC Med Genet. 2009 Jun 7;10:52.PMID: 19500413 [PubMed - indexed for MEDLINE]Related articlesFree article

Peroxisome proliferator-activated receptor-gamma gene polymorphism and risk of cardiovascular disease in patients with diabetic nephropathy.

Szeto CC, Chow KM, Poon PY, Kwan BC, Li PK.

Am J Nephrol. 2008;28(5):715-22. Epub 2008 Apr 17.PMID: 18417957 [PubMed - indexed for MEDLINE]Related articles

Peroxisome proliferator-activated receptor-gamma2 P12A polymorphism and risk of coronary heart disease in US men and women.

Pischon T, Pai JK, Manson JE, Hu FB, Rexrode KM, Hunter D, Rimm EB.

Arterioscler Thromb Vasc Biol. 2005 Aug;25(8):1654-8. Epub 2005 May 26.PMID: 15920035 [PubMed - indexed for MEDLINE]Related articlesFree article

Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 (PPARgamma-2) gene is associated with greater insulin sensitivity and decreased risk of type 2 diabetes in an Iranian population.

Meshkani R, Taghikhani M, Larijani B, Bahrami Y, Khatami S, Khoshbin E, Ghaemi A, Sadeghi S, Mirkhani F, Molapour A, Adeli K.

Clin Chem Lab Med. 2007;45(4):477-82.PMID: 17439324 [PubMed - indexed for MEDLINE]Related articles

Association between the Pro12Ala variant of the peroxisome proliferator-activated receptor-gamma2 gene and increased 24-h diastolic blood pressure in obese patients with type II diabetes.

Stefański A, Majkowska L, Ciechanowicz A, Frankow M, Safranow K, Parczewski M, Moleda P, Pilarska K.

J Hum Hypertens. 2006 Sep;20(9):684-92. Epub 2006 Apr 20.PMID: 16625233 [PubMed - indexed for MEDLINE]Related articles

PPAR-gamma2 Pro12Ala variant is associated with greater insulin sensitivity in childhood obesity.

Buzzetti R, Petrone A, Caiazzo AM, Alemanno I, Zavarella S, Capizzi M, Mein CA, Osborn JA, Vania A, di Mario U.

Pediatr Res. 2005 Jan;57(1):138-40. Epub 2004 Nov 5.PMID: 15531738 [PubMed - indexed for MEDLINE]Related articles

PPARgamma Pro12Ala Pro/Pro and resistin SNP-420 G/G genotypes are synergistically associated with plasma resistin in the Japanese general population.

Osawa H, Tabara Y, Kawamoto R, Ohashi J, Ochi M, Onuma H, Nishida W, Yamada K, Nakura J, Miki T, Makino H, Kohara K.

Clin Endocrinol (Oxf). 2009 Sep;71(3):341-5. Epub 2008 Oct 30.PMID: 19178525 [PubMed - indexed for MEDLINE]Related articles

The Pro12Ala variant at the peroxisome proliferator-activated receptor gamma gene and change in obesity-related traits in the Diabetes Prevention Program.

Franks PW, Jablonski KA, Delahanty L, Hanson RL, Kahn SE, Altshuler D, Knowler WC, Florez JC; Diabetes Prevention Program Research Group.

Diabetologia. 2007 Dec;50(12):2451-60. Epub 2007 Sep 27.PMID: 17898990 [PubMed - indexed for MEDLINE]Related articlesFree article

The association of Pro12Ala polymorphism of peroxisome proliferator-activated receptor-gamma gene with serum osteoprotegerin levels in healthy Korean women.

Rhee EJ, Oh KW, Yun EJ, Jung CH, Park CY, Lee WY, Oh ES, Baek KH, Kang MI, Park SW, Kim SW.

Exp Mol Med. 2007 Dec 31;39(6):696-704.PMID: 18160840 [PubMed - indexed for MEDLINE]Related articlesFree article

Peroxisome proliferator-activated receptor gamma-2 P12A polymorphism and risk of acute myocardial infarction, coronary heart disease and ischemic stroke: a case-cohort study and meta-analyses.

Zafarmand MH, van der Schouw YT, Grobbee DE, de Leeuw PW, Bots ML.

Vasc Health Risk Manag. 2008;4(2):427-36.PMID: 18561518 [PubMed - indexed for MEDLINE]Related articlesFree article

Peroxisome proliferator-activated receptor-gamma2 Pro12Ala and endothelial nitric oxide synthase-4a/b gene polymorphisms are not associated with hypertension in diabetes mellitus type 2.

Gouni-Berthold I, Giannakidou E, Müller-Wieland D, Faust M, Kotzka J, Berthold HK, Krone W.

J Hypertens. 2005 Feb;23(2):301-8.PMID: 15662218 [PubMed - indexed for MEDLINE]Related articles

Peroxisome proliferator-activated receptor gamma polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes.

Pollex RL, Mamakeesick M, Zinman B, Harris SB, Hegele RA, Hanley AJ.

J Diabetes Complications. 2007 May-Jun;21(3):166-71.PMID: 17493550 [PubMed - indexed for MEDLINE]Related articles